Autologous Bone Marrow Transplantation (ABMT) and High-Dose Chemotherapy in Small Cell Lung Cancer

  • J. Gordon McVie
Part of the Cancer Treatment and Research book series (CTAR, volume 24)

Abstract

Chemotherapy is accepted as the logical therapy for small cell lung cancer. The heterogeneity of this tumor combined with a fast doubling time and propensity to early metastatic spread make it a formidable opponent. Whereas combinations of cytostatic drugs have achieved impressive response rates in the last 10 years, when these response rates are dissected down into complete and less than complete only the former have been shown to benefit the patient [1]. Results have been reported in an incorrect and confusing manner in the majority of trials leading to overoptimism based on an overall response and ‘median survival’ times. As is too often the case with early reporting of results, the final results reveal the stark reality of long term survival statistics. Only a small number of patients treated with combination chemotherapy plus or minus local radiotherapy will achieve meaningful long term survival which may or may not be termed as cure. Those patients almost always have limited disease (that is limited to the thorax) and achieve complete remission rather quickly after chemotherapy. The converse is true that few patients with extensive disease have rarely achieved long term survival and no patient who only achieved partial remission survived 5 years.

Keywords

Magnetite Doxorubicin Melphalan Cyclophosphamide Neuroblastoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Comis RL: Small cell carcinoma of the lung. Cancer Treat Rev 9:237–258, 1982.PubMedCrossRefGoogle Scholar
  2. 2.
    Cohen MH, Creaven PI, Fossieck JR, Broder LE, Selawry OS, Johnston AV, Williams CL, Minna JD: Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep 61:349–354, 1977.PubMedGoogle Scholar
  3. 3.
    Johnston RE, Brereton HD, Kent CH: Total therapy for small cell carcinoma of the lung. Ann Thorac Surg 25:510–515, 1978.CrossRefGoogle Scholar
  4. 4.
    Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL: Marrow transplantation for acute non-lymphoblastic leukaemia in first remission N Eng J Med 301:597–599, 1979.CrossRefGoogle Scholar
  5. 5.
    Souhami RL, Harper PG, Linch D, Trask C, Goldstone AH, Tobias AH, Spiro SG, Geddes DM, Richards JD: High-dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus. Cancer Chemother Pharmacol 8:31–34, 1982.PubMedCrossRefGoogle Scholar
  6. 6.
    Norton L, Simon R: Tumour size sensitivity to therapy and design of treatment schedules. Cancer Treat Rep 61:1307–1317, 1977.PubMedGoogle Scholar
  7. 7.
    de Vries EGE, Meinesz AF, Daenen S, Mulder NH, Postmus PE, Sleijfer DTh, Vriesendorp R: Bone marrow harvest without general anesthesia for autologous bone marrow transplantation. In: Autologous Bone Marrow Transplantation and Solid Tumours. McVie JG, Dalesio O, Smith IE (eds). New York, Raven Press, 1984.Google Scholar
  8. 8.
    McElwain TT, Hedley DW, Burton G, Clink HM, Gordon MY, Jarman M, Juttner CA, Millar JL, Milsted RAV, Prentice G, Smith IE, Spence D, Woods M: Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. Br J Cancer 40:72–80, 1979.PubMedCrossRefGoogle Scholar
  9. 9.
    Delforge A, Range-Collard E, Stryckmans P, Spiro T, Malarme MA: Granulocyte-macrophage progenitor cell preservation at 4°C. Br J Haemat 53:49–54, 1983.CrossRefGoogle Scholar
  10. 10.
    Tansey P, Burnett AK, Hill C, Alcorn MJ, Singer CRJ: Haematological reconstitution following supralethal chemoradiotherapy using autologous bone marrow stored at 4°C. Exp Haemat 11 (suppl. 13): 173, 1983.Google Scholar
  11. 11.
    Redding WH, Coombes RC, Neville AM, Ormerod M, Powles TJ, Ford HT, Gazet JC: Detection of marrow micrometastasesin primary breast cancer. Proc of 3rd EORTC Breast Cancer Working Conference, 111:10, 1983.Google Scholar
  12. 12.
    Kemshead JT, Gibson FJ, Ugelstad J, Rembaum A: A flow system for the in vitro separation of tumour cells from bone marrow using monoclonal antibodies and magnetic microspheres. Proc Am Assoc Cancer Res 24:217, 1983.Google Scholar
  13. 13.
    Korbling M, Fliedner TM, Uckun F, Hunstein W: Elimination of residual tumor cells from the autologous stem cell graft by chemoseparation. In: Autologous Bone Marrow Transplantation and Solid Tumors. McVie JG, Dalesio O, Smith IE (eds). New York, Raven Press, 1984.Google Scholar
  14. 14.
    Scheaf W, Oklein H, Brock N: Controlled studies with an antidote against the urotoxicity of oxazophorines. Cancer Treat Rep 63:501–505, 1979.Google Scholar
  15. 15.
    McElwain TJ, Hedley DW, Gordon MY, Jarman M, Millar J, Pritchard J: Hich-dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma. Exp Hemat 7:360–371, 1979.PubMedGoogle Scholar
  16. 16.
    Wolff SN, Fer MF, McKay C, Hainsworth J, Hawde KR, Greco FA: High-dose VP16 and autologous bone marrow transplantation for advanced malignancies - a phase I study. Proc Am Assoc Cancer Res 23:134, 1982.Google Scholar
  17. 17.
    Smith IE, Evans BD, Harland SJ, Millar JL: Autologous bone marrow rescue is unnecessary after very high dose cyclophosphamide. Lancet 1:8, 1983.Google Scholar
  18. 18.
    Glode LM, Robinson WA, Hartmann DW, Klein JJ, Thomas MR, Morton N: Autologous bone marrow transplantation in the therapy of small cell carcinoma of the lung. Cancer Res 43:4270–4275, 1982.Google Scholar
  19. 19.
    Gale RP, Graze PR, Wells J, Ho W, Cline M J: Autologous bone marrow transplantation in patients with cancer. Exp Haematol (suppl. 5), 7:35–39, 1979.Google Scholar
  20. 20.
    Postmus PE, de Vries-Hospers HG, Sleijfer DTh, van Imhoff GW, Meinesz AF, Vriesendorp R, Mulder NH, de Vries EGE: Failure of selective gut decontamination with nonabsorbable antibiotics in preventing infections in patients treated with high-dose chemotherapy and autologous bone marrow transplantation. In: Autologous bone Marrow Transplantation and Solid Tumors. McVie JG, Dalesio O, Smith IE (eds), New York, Raven Press, 1984.Google Scholar
  21. 21.
    Soukop M, Ahmedza S, Banham S, Burnett A, Cunningham D, Dorward A, Hutcheon A, Lucie N, Kaye S, Stevenson R, Tansey T: Late Intensification chemotherapy in small cell lung cancer. In: Autologous Bone Marrow Transplantation and Solid Tumors. McVie JG, Dalesie O, Smith IE (eds), New York, Raven Press, 1984.Google Scholar
  22. 22.
    Ihde DC, Lichter AS, Deisseroth AB, Bunn P, Carney DN, Cohen MH, Makuch RW, Johnston-Early A, Minna JD: Late intensive combined modality therapy with autolous bone marrow infusion in extensive stage small cell lung cancer. Proc Am Assoc Clin Oncol 2:198, 1983.Google Scholar
  23. 23.
    Pico JL, Beaujean F, Debré M, Carde P, LLE Chevalier T, Hayat M: High-dose chemotherapy with autologous bone marrow transplantation in small cell lung carcinoma in relapse. Proc Am Soc Clin Oncol 2:206, 1983.Google Scholar
  24. 24.
    Syman M, Bosly A, Humblet Y, Delaunois L, Steyaert J, Francis C, Machiels J, Prignot J: Late intensification the apy and autologous bone marrow transplantation in small cell lung cancer. Proc 13th Internat Congress Chemother 232:20–24, 1983.Google Scholar
  25. 25.
    Mulder NH, Meinesz AF, Sleijfer DTh, Postmus PE, de Vries EGE, Smit Sibinga CTH, Vriesendorp R: High-dose etoposide with or without cyclophosphamide and autologous bone marrow transplantation in solid tumours. In: Autologous Bone Marrow Transplantation and solid tumors. McVie JG, Dalesio O, Smith IE (eds), New York, Raven press, 1984.Google Scholar
  26. 26.
    Farha P, Spitzer G, Valdivieso M, Zander A, Verma D, Minnhaar G, Vellekoop L, Dicke K, Bodey G: Treatment of small cell bronchogenic carcinoma with high-dose chemotherapy and autologous bone marrow transplantation. Proc AACR and ASCO 22:496, 1981.Google Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1985

Authors and Affiliations

  • J. Gordon McVie

There are no affiliations available

Personalised recommendations